SEC Form 4 · accession 0001209191-18-045055
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Huyett
Officer — Chief Operating Officer
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 31, 2018 | A | 12,000 | $0.00 | A | 68,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock unit award, granted as a recognition award, vests as to 100% of the shares of Class A Common Stock on May 9, 2019.